Carbamazepine drug reaction involving high fevers during the COVID-19 era

• 主要な著者: Reuben Heyman-Kantor, MD (著者), Matthew Perez, MD (著者), Arti Phatak, PharmD, BCPS (著者), Danielle L. Anderson, MD (著者)
• フォーマット: 図書
• 出版事項: American Association of Psychiatric Pharmacists, 2021-09-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Carbamazepine has demonstrated anticonvulsant properties and is used for a variety of indications in psychiatry and neurology. Total daily doses typically range from 200 to 1200 mg/d, generally divided into 2 doses. Carbamazepine has a broad side-effect profile but is not typically thought to produc...